Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GraniteShares 2x Long COIN Daily ETF (CONL) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

GraniteShares 2x Long COIN Daily ETFTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

GraniteShares 2x Long COIN Daily ETF vs Citius Pharmaceuticals Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $4.15, while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Citius Pharmaceuticals Inc is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals.

CONLCTXR
Sector
Leveraged / InverseHealth
52-Week High
$48.70$1.82
52-Week Low
$3.93$0.48
Market Cap
$20.01M
Enterprise Value
$16.23M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GraniteShares 2x Long COIN Daily ETF

No Aura AI signal available yet.

Citius Pharmaceuticals Inc

CTXR is trading at $0.68, up 6.28% today, with a bullish technical signal from moving averages. The company shows strong commercial momentum with LYMPHIR cancer treatment revenue reaching $5.6 million in H1 2026, though it remains unprofitable with a -823% net margin. Analyst consensus is strongly bullish with 83% buy ratings.

The outlook depends on LYMPHIR's commercial success offsetting deep losses. Near-term catalysts include expanded market access and combination therapy data, but high cash burn and execution risks require monitoring. The stock offers speculative growth potential in oncology but carries significant financial risk.

Returns comparison

Trailing returns across standard periods

About GraniteShares 2x Long COIN Daily ETF

CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.

Read more on CONL

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR